Anti‐Siglec‐15 Antibody Prevents Marked Bone Loss after Acute Spinal Cord Injury‐Induced Immobilization in Rats

ABSTRACT Rapid and extensive sublesional bone loss after spinal cord injury (SCI) is a difficult medical problem that has been refractory to available interventions except the antiresorptive agent denosumab (DMAB). While DMAB has shown some efficacy in inhibiting bone loss, its concurrent inhibition...

Full description

Bibliographic Details

Published in:	JBMR Plus
Main Authors:	Yuanzhen Peng, Solomon Langermann, Priyanka Kothari, Linda Liu, Wei Zhao, Yizhong Hu, Zihao Chen, Mariana Moraes de Lima Perini, Jiliang Li, Jay Cao, X. Edward Guo, Lieping Chen, William A. Bauman, Weiping Qin
Format:	Article
Language:	English
Published:	Oxford University Press 2023-12-01
Subjects:	BONE FORMATION BONE RESORPTION IMMOBILIZATION SIGLEC‐15 SPINAL CORD INJURY
Online Access:	https://doi.org/10.1002/jbm4.10825